Why are coding bootcamps declining amid AI growth?
How will Trump's Fed pick affect central bank independence?
Why are electric bills rising due to data centers?
How did Trump tariffs impact US and global trade?
What caused Cathie Wood to sell popular AI stocks?
Why is Hong Kong’s restaurant sector shifting?
How is AI changing job prospects for college grads?
LENZ Therapeutics' Eye Drop Scores First FDA Approval For Age-Related Blurred Vision Condition Impacting 128 Million People
benzinga.com/news/fda/25/08/46796085/lenz-therapeutics-eye-drop-scores-first-fda-approval-for-age-related-blurred-vision-condition-impacting-
On Thursday, the U.S. Food and Drug Administration approved LENZ Therapeutics, Inc.’s (NASDAQ:LENZ) VIZZ (aceclidine ophthalmic solution, previously known as LNZ100) 1.44%, the first and only FDA-approved aceclidine-based eye drop for presbyopia in adults.
Presbyopia is an age-related…
This story appeared on benzinga.com, 2025-08-01 14:25:51.